[
Asawanonda, P., Nateetongrungsak, Y. (2006). Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: A randomized, placebo-controlled study. J. Amer. Acad. Dermatol., 54, 1013–1018.
]Search in Google Scholar
[
Attwa, E. M., Elkot, R. A., Abdelshafey, A. S., Hafez, A. R. (2019). Subcutaneous methotrexate versus oral form for the treatment and prophylaxis of chronic plaque psoriasis. Dermatol Ther., 32, 13051.
]Search in Google Scholar
[
Boffa, M., Chalmers, R. (1996). Methotrexate for psoriasis. Clin. Exp. Dermatol., 21, 399–408.
]Search in Google Scholar
[
Carling, D. (2007). The role of the AMP-activated protein kinase in the regulation of energy homeostasis. Novartis Found Symp., 286, 72–81.
]Search in Google Scholar
[
European S3 guidelines (2009). European S3 guidelines in the systemic treatment of psoriasis vulgaris. J. Eur. Acad. Dermatol. Venereol., Suppl 2, 1–70.
]Search in Google Scholar
[
Goktas, E. O., Aydin, F., Senturk, N., Canturk, M. T., Turanli, A. Y. (2006). Mechanism of ultraviolet (UV) B and UVA phototherapy. JEADV, 20, 553–557.
]Search in Google Scholar
[
Griffiths, C. E., Barker, J. N. (2007). Pathogenesis and clinical features of psoriasis. Lancet, 370, 263–271.
]Search in Google Scholar
[
Hartmane, I., Mikažāns, I., Ivdra, I., Ķīsis, J. (2016). Vidēji smagas un smagas gaitas psoriāzes klīniskās vadlīnijas [Guidelines for treatment moderate and severe psoriasis] (in Latvian). https://www.spkc.gov.lv/lv/registretas-2016gada/5735c550ebf101.pdf (accessed 20.03.2024).
]Search in Google Scholar
[
Hartmane, I., Mikazans, I, Ivdra, I, Derveniece (2017). Evaluation of clinical efficacy and safety in treatment of patients with moderate and severe forms of psoriasis with combined low dose methotrexate and narrow band UVB therapy. In: Collection of Scientific Papers: Research articles in medicine & pharmacy. / Rīga Stradiņš University,- Riga, pp. 5–10. https://www.rsu.lv/en/scientific-papers/evaluation-clinical-efficacy-and-safety-treatment-patients-moderate-and-severe (accessed 20.03.2024).
]Search in Google Scholar
[
Hartmane, I., Mikažāns, I, Ivdra, I, Dērveniece, A, (2016). Experience of phototherapy in dermatological praxis in complex therapy of psoriasis patients. Proc. Latv. Acad. Sci., Section B, 70 (1), 7–12.
]Search in Google Scholar
[
Hartmane, I., Ivdra, I., Mikažāns, I., Bondare-Ansberga, V. (2021). Immunopathogenic treatment options for psoriasis patients under a restrictive reimbursement environment. Proc. Latv. Acad. Sci., Section B, 75 (3), 158–166.
]Search in Google Scholar
[
Lebwohl, M., Menter, A., Koo, J., Feldman, S. R. (2004). Combination therapy to treat moderate to severe psoriasis. J. Amer. Acad. Dermatol., 50, 416–430.
]Search in Google Scholar
[
Mahajan, R., Kaur, I., Kanwar, A. J. (2010). Methotrexate/narrowband UVB phototherapy combination vs. narrowband UVB phototherapy in the treatment of chronic plaque-type psoriasis: A randomized single-blinded placebo-controlled study, J. Eur. Acad. Dermatol. Venereol., 24 (5), 595–600
]Search in Google Scholar
[
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A., Koo, J. Y. M., Lebwohl, M., Lim, H. W., Van Voorhees, A. S., Beutner, K. R., Bhushan, R. (2010). Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J. Amer. Acad. Dermatol., 62, 114–135.
]Search in Google Scholar
[
Paul, B. S., Momtaz, R., Stern, S., Arndt, K. A., Parrish, J. A. (1982). Combined methotrexate-ultraviolet B therapy in the treatment of psoriasis. J. Amer. Acad. Dermatol., 53, 758–762.
]Search in Google Scholar
[
Pichlmeier, U., Heuer K. U. (2014). Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate. Clin. Exp. Rheumatol., 32, 563–571.
]Search in Google Scholar
[
Puig, L. (2014). Methotrexate: New therapeutic approaches. Actas Dermosifiliogr, 105, 583–589.
]Search in Google Scholar
[
Rácz, E, Prens, E. P., Kurek, D., Kant, M., de Ridder, D., Mourits, S., Baerveldt, E.M., Ozgur Z., van IJcken, W. F., Laman, J. D., Staal, F. J., van der Fits, L. (2011). Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways. J. Invest. Dermatol., 131 (7),1547–1558.
]Search in Google Scholar
[
Rendon, A., Schakel, K. (2019). Psoriasis pathogenesis and treatment. Int. J. Mol. Sci., 20, 1–28.
]Search in Google Scholar
[
Roubille, C., Riche, R., V., Starnino, T., McCour, T., C., McFarlane, A., Fleming, P., Siu, S., Kraft, J., Lynde, C., Pope, J., Gulliver, W., Keeling, S., Dutz, J., Bessette, L., Bissonnette, R., Haraoui, B. (2015). The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: A systematic review and meta-analysis. Ann. Rheum. Dis., 74, 480–489.
]Search in Google Scholar
[
Schmitt, J., Zhang, Z., Wozel, G., Meurer, M., Kirch, W. (2008). Efficacy and tolerability of biologic and non-biologic systemic treatments for moderate to severe psoriasis: Meta- analysis of randomized controlled trials. Brit. J. Dermatol., 159, 513–526.
]Search in Google Scholar
[
Soliman, A., Nofa A., Fatm, A., D., Asal, M. (2015). Combination therapy of methotrexate plus NBUVB phototherapy is more effective than methotrexate monotherapy in the treatment of chronic plaque psoriasis J. Dermatol. Treat., 26, 528–534.
]Search in Google Scholar
[
Tournier, A., Khemis, A., Maccari, F., Reguiai, Z., Bégon, E., Fougerousse A.C., Amy de la Breteque, M., Beneton, N., Parier, J., Boyé, T., et al. (2019). Methotrexate efficacy and tolerance in plaque psoriasis. A prospective real-life multicentre study in France. Resopso, Tournier. Ann. Dermatol. Venereol., 146, 106–114.
]Search in Google Scholar
[
Van, E. D., Diem, T. P., Thi., V. B., Thi., T. H., Xuan, T., Tuan, K.L. (2019). Successful psoriasis treatment using NB-UVB with methotrexate: The Vietnamese experience. J. Med. Sci., 27, 253–255.
]Search in Google Scholar
[
Wang, W., Zhou, H., Liu, L., Wang, W. (2018). Side effects of methotrexate therapy for rheumatoid arthritis: Asystematic review. Eur. J. Med. Chem., 158, 502–516.
]Search in Google Scholar
[
Warren, R. B., Mrowietz, U., von Kiedrowski, R., Niesmann, J., Wilsmann-Theis, D., Ghoreschi, K., Zschocke, I., Falk, T.M., Blödorn-Schlicht, N., Reich, K. (2017). An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque- type psoriasis (METOP): A 52 week, multicenter, randomized, double-blind, placebo-controlled, phase 3 trial. Lancet., 389, 528–537.
]Search in Google Scholar
[
Yan, K., Xu, W., Huang, Y. (2018). Methotrexate restores the function of peripheral blood regulatory T cells in psoriasis vulgaris via the CD73/AMPK/mTOR pathway. Brit. J. Dermatol., 179, 896–905.
]Search in Google Scholar
